Follow
Nathaniel J. Rhodes
Title
Cited by
Cited by
Year
Vancomycin area under the curve and acute kidney injury: a meta-analysis
DM Aljefri, SN Avedissian, NJ Rhodes, MJ Postelnick, K Nguyen, ...
Clinical Infectious Diseases 69 (11), 1881-1887, 2019
1482019
Prolonged infusion piperacillin-tazobactam decreases mortality and improves outcomes in severely ill patients: results of a systematic review and meta-analysis
NJ Rhodes, J Liu, JN O’Donnell, JM Dulhunty, MH Abdul-Aziz, PY Berko, ...
Critical care medicine 46 (2), 236-243, 2018
1052018
Treatment outcomes with cefazolin versus oxacillin for deep-seated methicillin-susceptible Staphylococcus aureus bloodstream infections
SN Rao, NJ Rhodes, BJ Lee, MH Scheetz, AP Hanson, J Segreti, ...
Antimicrobial agents and chemotherapy 59 (9), 5232-5238, 2015
832015
A review of the clinical pharmacokinetics of polymyxin B
SN Avedissian, J Liu, NJ Rhodes, A Lee, GM Pais, AR Hauser, ...
Antibiotics 8 (1), 31, 2019
802019
Population pharmacokinetics of polymyxin B in acutely ill adult patients
C Miglis, NJ Rhodes, SN Avedissian, CJ Kubin, MT Yin, BC Nelson, ...
Antimicrobial Agents and Chemotherapy 62 (3), 10.1128/aac. 01475-17, 2018
782018
Vancomycin‐induced kidney injury: animal models of toxicodynamics, mechanisms of injury, human translation, and potential strategies for prevention
GM Pais, J Liu, S Zepcan, SN Avedissian, NJ Rhodes, KJ Downes, ...
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 40 (5 …, 2020
632020
Evaluation of vancomycin exposures associated with elevations in novel urinary biomarkers of acute kidney injury in vancomycin-treated rats
NJ Rhodes, WC Prozialeck, TP Lodise, N Venkatesan, JN O'Donnell, ...
Antimicrobial agents and chemotherapy 60 (10), 5742-5751, 2016
612016
β-Lactam pharmacodynamics in Gram-negative bloodstream infections in the critically ill
G Wong, F Taccone, P Villois, MH Scheetz, NJ Rhodes, S Briscoe, ...
Journal of Antimicrobial Chemotherapy 75 (2), 429-433, 2020
602020
Defining clinical exposures of cefepime for Gram-negative bloodstream infections that are associated with improved survival
NJ Rhodes, JL Kuti, DP Nicolau, S Van Wart, AM Nicasio, J Liu, BJ Lee, ...
Antimicrobial agents and chemotherapy 60 (3), 1401-1410, 2016
602016
Resistance trends and treatment options in gram-negative ventilator-associated pneumonia
NJ Rhodes, CE Cruce, JN O’Donnell, RG Wunderink, AR Hauser
Current infectious disease reports 20, 1-15, 2018
552018
Impact of loading doses on the time to adequate predicted beta-lactam concentrations in prolonged and continuous infusion dosing schemes
NJ Rhodes, SH MacVane, JL Kuti, MH Scheetz
Clinical infectious diseases 59 (6), 905-907, 2014
542014
Population pharmacokinetics of intravenous polymyxin B from clinical samples
CJ Kubin, BC Nelson, C Miglis, MH Scheetz, NJ Rhodes, SN Avedissian, ...
Antimicrobial Agents and Chemotherapy 62 (3), 10.1128/aac. 01493-17, 2018
502018
24-hour pharmacokinetic relationships for vancomycin and novel urinary biomarkers of acute kidney injury
JN O'Donnell, NJ Rhodes, TP Lodise, WC Prozialeck, CM Miglis, ...
Antimicrobial agents and chemotherapy 61 (11), 10.1128/aac. 00416-17, 2017
482017
Optimal timing of oral fosfomycin administration for pre-prostate biopsy prophylaxis
NJ Rhodes, BJ Gardiner, MN Neely, ML Grayson, AG Ellis, ...
Journal of antimicrobial chemotherapy 70 (7), 2068-2073, 2015
452015
Lack of synergistic nephrotoxicity between vancomycin and piperacillin/tazobactam in a rat model and a confirmatory cellular model
GM Pais, J Liu, SN Avedissian, D Hiner, T Xanthos, A Chalkias, E d’Aloja, ...
Journal of antimicrobial chemotherapy 75 (5), 1228-1236, 2020
442020
Student characteristics associated with successful matching to a PGY1 residency program
JA Phillips, MM McLaughlin, C Rose, JC Gallagher, JP Gettig, NJ Rhodes
American Journal of Pharmaceutical Education 80 (5), 84, 2016
442016
Comparative performance of urinary biomarkers for vancomycin-induced kidney injury according to timeline of injury
GM Pais, SN Avedissian, JN O’Donnell, NJ Rhodes, TP Lodise, ...
Antimicrobial agents and chemotherapy 63 (7), 10.1128/aac. 00079-19, 2019
422019
Piperacillin-tazobactam added to vancomycin increases risk for acute kidney injury: fact or fiction?
SN Avedissian, GM Pais, J Liu, NJ Rhodes, MH Scheetz
Clinical infectious diseases 71 (2), 426-432, 2020
412020
Polymyxin B pharmacokinetics in adult cystic fibrosis patients
SN Avedissian, C Miglis, CJ Kubin, NJ Rhodes, MT Yin, S Cremers, ...
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 38 (7 …, 2018
412018
An exploratory analysis of the ability of a cefepime trough concentration greater than 22 mg/L to predict neurotoxicity
NJ Rhodes, JL Kuti, DP Nicolau, MN Neely, AM Nicasio, MH Scheetz
Journal of Infection and Chemotherapy 22 (2), 78-83, 2016
352016
The system can't perform the operation now. Try again later.
Articles 1–20